BEAUTY FARM MEDICAL AND HEALTH INDUSTRY INC.

Income Statement Beauty Farm Medical and Health Industry Inc.

Equities

2373

KYG0929L1041

Personal Services

Delayed Hong Kong S.E. Other stock markets 12:32:20 12/02/2026 pm IST			5-day change	1st Jan Change
26.22 ^HKD	+1.39%		+6.24%	-3.68%

20/01	Beauty Farm Medical Forecasts At least 34% Higher Profit in 2025	MT
19/01	Beauty Farm Medical and Health Industry Inc. Provides Unaudited Consolidated Earning Guidance for the Year Ended December 31, 2025	CI

a0da18583f8d5a6fc55adcb25254.e8b3d6fM3db13njhMDXpZw27kDhiAU3GGVC64cFtUZ8.HY2TEOn-mKSYq0qZCXbeSkWL0U5SLDmobD_shbc7Pc85rbQj5K6vrqXnCw

Published financial data: BEAUTY FARM MEDICAL AND HEALTH INDUSTRY INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	150.33Cr	178.07Cr	163.54Cr	214.51Cr	257.22Cr
Total Revenues	150.33Cr	178.07Cr	163.54Cr	214.51Cr	257.22Cr
Cost of Goods Sold, Total	80Cr	95Cr	92Cr	116.8Cr	138.22Cr
Gross Profit	70Cr	83Cr	72Cr	98Cr	119Cr
Selling General & Admin Expenses, Total	49Cr	57Cr	58Cr	70Cr	85Cr
Provision for Bad Debts	-20.15L	13.06L	2L	-54T	39.06L
R&D Expenses	1.27Cr	1.8Cr	3.12Cr	3.41Cr	3.6Cr
Other Operating Expenses	-91.41L	-1.5Cr	-2.44Cr	-2.24Cr	-90.34L
Other Operating Expenses, Total	50Cr	58Cr	58Cr	71Cr	88Cr
Operating Income	20Cr	26Cr	14Cr	27Cr	31Cr
Interest Expense, Total	-2.59Cr	-2.42Cr	-2.47Cr	-2.48Cr	-2.76Cr
Interest And Investment Income	11.34L	12.83L	30.94L	2.18Cr	2.36Cr
Net Interest Expenses	-2.48Cr	-2.29Cr	-2.16Cr	-29.74L	-39.41L
Income (Loss) On Equity Invest.	-	-	-	-51T	-
Currency Exchange Gains (Loss)	-5L	-2L	40.3L	3L	-25.51L
Other Non Operating Income (Expenses)	-	-	-	-8L	9L
EBT, Excl. Unusual Items	18Cr	23Cr	12Cr	27Cr	30Cr
Gain (Loss) On Sale Of Investments	1.34Cr	2.34Cr	2.07Cr	2.38Cr	2.09Cr
Gain (Loss) On Sale Of Assets	-35.72L	-26.4L	-9L	-10.08L	-70.76L
Other Unusual Items	-	-	-72.79L	-	4L
EBT, Incl. Unusual Items	19Cr	26Cr	13Cr	29Cr	32Cr
Income Tax Expense	3.63Cr	4.68Cr	1.99Cr	5.81Cr	6.54Cr
Earnings From Continuing Operations	15Cr	21Cr	11Cr	23Cr	25Cr
Net Income to Company	15Cr	21Cr	11Cr	23Cr	25Cr
Minority Interest	-12.26L	-1.49Cr	-74.23L	-1.45Cr	-2.4Cr
Net Income - (IS)	15Cr	19Cr	10Cr	22Cr	23Cr
Net Income to Common Incl Extra Items	15Cr	19Cr	10Cr	22Cr	23Cr
Net Income to Common Excl. Extra Items	15Cr	19Cr	10Cr	22Cr	23Cr
Per Share Items
Net EPS - Basic	0.76	0.97	0.52	0.94	0.99
Basic EPS - Continuing Operations	0.76	0.97	0.52	0.94	0.99
Basic Weighted Average Shares Outstanding	20Cr	20Cr	20Cr	23Cr	23Cr
Net EPS - Diluted	0.76	0.97	0.52	0.94	0.99
Diluted EPS - Continuing Operations	0.76	0.97	0.52	0.94	0.99
Diluted Weighted Average Shares Outstanding	20Cr	20Cr	20Cr	23Cr	23Cr
Normalized Basic EPS	0.55	0.66	0.33	0.66	0.72
Normalized Diluted EPS	0.55	0.66	0.33	0.66	0.72
Dividend Per Share	-	-	0.34	0.43	0.48
Payout Ratio	70.72	41.95	198.1	40.34	49.24
Supplemental Items
EBITDA	30Cr	36Cr	24Cr	39Cr	45Cr
EBITA	21Cr	27Cr	15Cr	28Cr	33Cr
EBIT	20Cr	26Cr	14Cr	27Cr	31Cr
EBITDAR	31Cr	37Cr	25Cr	40Cr	48Cr
Effective Tax Rate - (Ratio)	19.28	18.33	15.28	20.17	20.58
Current Domestic Taxes	4.2Cr	4.49Cr	2.94Cr	4.13Cr	3.46Cr
Total Current Taxes	4.2Cr	4.49Cr	2.94Cr	4.13Cr	3.46Cr
Deferred Domestic Taxes	-	-	-92.47L	1.54Cr	2.92Cr
Total Deferred Taxes	-64.13L	34.61L	-92.47L	1.54Cr	2.92Cr
Normalized Net Income	11Cr	13Cr	6.63Cr	15Cr	17Cr
Interest on Long-Term Debt	2.48Cr	2.42Cr	2.47Cr	2.48Cr	2.45Cr
Supplemental Operating Expense Items
Marketing Expenses	2.44Cr	3.34Cr	3.65Cr	4.41Cr	5.11Cr
Selling and Marketing Expenses	27Cr	30Cr	29Cr	38Cr	46Cr
General and Administrative Expenses	22Cr	27Cr	29Cr	32Cr	39Cr
Research And Development Expense From Footnotes	1.27Cr	1.8Cr	3.12Cr	3.41Cr	3.6Cr
Net Rental Expense, Total	73.31L	98.97L	1.05Cr	1.66Cr	2.93Cr
Imputed Operating Lease Interest Expense	28.04L	37.19L	39.78L	60.38L	99.85L
Imputed Operating Lease Depreciation	45.27L	61.78L	64.94L	1.05Cr	1.93Cr
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	-4L
Stock-Based Comp., Other (Total)	69.88L	62.9L	1.42Cr	1.09Cr	-
Total Stock-Based Compensation	69.88L	62.9L	1.42Cr	1.09Cr	-4L

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	14Cr	16Cr	16Cr	22Cr	46Cr
Short Term Investments	-	-	12Cr	38Cr	46Cr
Trading Asset Securities, Total	66Cr	93Cr	63Cr	96Cr	91Cr
Total Cash And Short Term Investments	80Cr	108.36Cr	91Cr	157.42Cr	183.08Cr
Accounts Receivable, Total	3.67Cr	4.22Cr	5.76Cr	6.54Cr	5.69Cr
Other Receivables	1.4Cr	53.47L	1.43Cr	2.59Cr	1.79Cr
Notes Receivable	-	-	-	-	-
Total Receivables	5.07Cr	4.75Cr	7.19Cr	9.13Cr	7.48Cr
Inventory	9.44Cr	13Cr	19Cr	23Cr	21Cr
Restricted Cash	-	1.03Cr	1.03Cr	1.05Cr	2.84Cr
Other Current Assets, Total	3.97Cr	3.43Cr	6.98Cr	2.86Cr	4.48Cr
Total Current Assets	99Cr	130.95Cr	124.78Cr	193.59Cr	218.6Cr
Gross Property Plant And Equipment	134.74Cr	159.96Cr	174.78Cr	189.88Cr	209.26Cr
Accumulated Depreciation	-59Cr	-81Cr	-89Cr	-94Cr	-112.84Cr
Net Property Plant And Equipment	76Cr	79Cr	86Cr	95Cr	96Cr
Long-term Investments	2L	74T	47T	3L	75.91L
Goodwill	18Cr	19Cr	20Cr	22Cr	65Cr
Other Intangibles, Total	9.03Cr	9.03Cr	8.33Cr	8Cr	35Cr
Deferred Tax Assets Long-Term	3.6Cr	3.5Cr	4.42Cr	4.21Cr	4.17Cr
Other Long-Term Assets, Total	5.19Cr	6.24Cr	6.39Cr	7.19Cr	7.29Cr
Total Assets	210.32Cr	247.73Cr	249.54Cr	330.2Cr	427.65Cr
Liabilities
Accounts Payable, Total	1.78Cr	1.54Cr	78.57L	2.14Cr	2.99Cr
Accrued Expenses, Total	18Cr	22Cr	20Cr	24Cr	30Cr
Short-term Borrowings	63.7L	-	-	-	-
Current Portion of Long-Term Debt	-	-	-	-	1.98Cr
Current Portion of Leases	14Cr	16Cr	15Cr	17Cr	22Cr
Current Income Taxes Payable	3.45Cr	3.19Cr	3.4Cr	4.85Cr	4.23Cr
Unearned Revenue Current, Total	115.51Cr	134.77Cr	140.81Cr	149.25Cr	197.92Cr
Other Current Liabilities	5.33Cr	7.84Cr	11Cr	8.07Cr	15Cr
Total Current Liabilities	158.83Cr	185.38Cr	190.91Cr	205.2Cr	273.89Cr
Long-Term Debt	-	-	-	-	13Cr
Long-Term Leases	37Cr	35Cr	37Cr	39Cr	36Cr
Deferred Tax Liability Non Current	62.18L	87.44L	86.47L	2.2Cr	7.2Cr
Total Liabilities	196.25Cr	221.48Cr	229.23Cr	246.78Cr	330.12Cr
Common Stock, Total	-	-	7T	8T	8T
Additional Paid In Capital	-	-	8.44Cr	47Cr	36Cr
Retained Earnings	13Cr	19Cr	10Cr	32Cr	55Cr
Treasury Stock	-	-	-	-68.16L	-
Comprehensive Income and Other	74.52L	6.54Cr	20.98L	2.3Cr	3.84Cr
Total Common Equity	14Cr	26Cr	19Cr	80Cr	94Cr
Minority Interest	-2L	51.73L	1.44Cr	3.23Cr	3.06Cr
Total Equity	14Cr	26Cr	20Cr	83Cr	98Cr
Total Liabilities And Equity	210.32Cr	247.73Cr	249.54Cr	330.2Cr	427.65Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	20Cr	20Cr	24Cr	24Cr	24Cr
ECS Total Common Shares Outstanding	20Cr	20Cr	10Cr	24Cr	24Cr
Book Value / Share	0.71	1.29	1.83	3.4	4.01
Tangible Book Value	-13Cr	-2.72Cr	-9.08Cr	50Cr	-5.94Cr
Tangible Book Value Per Share	-0.63	-0.14	-0.88	2.14	-0.25
Total Debt	52Cr	52Cr	53Cr	56Cr	73Cr
Net Debt	-29Cr	-57Cr	-39Cr	-101.11Cr	-110.02Cr
Debt Equivalent Oper. Leases	5.86Cr	7.92Cr	8.38Cr	13Cr	23Cr
Minority Interest, Total (Incl. Fin. Div)	-2L	51.73L	1.44Cr	3.23Cr	3.06Cr
Equity Method Investments, Total	-	-	-	2L	-
Account Code - Inventory Valuation	-	6	6	6	6
Inventories - Finished Goods, Total	7.1Cr	10Cr	15Cr	20Cr	16Cr
Land - (BS)	7.81Cr	7.8Cr	7.45Cr	7.8Cr	7.8Cr
Buildings, Total	4.08Cr	4.08Cr	4.08Cr	4.08Cr	4.08Cr
Machinery, Total	17Cr	21Cr	24Cr	31Cr	36Cr
Full Time Employees	-	-	3.71T	3.94T	5.61T
Accumulated Allowance for Doubtful Accounts (Supple)	22.6L	24.93L	24.68L	24.14L	63.2L

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	15Cr	19Cr	10Cr	22Cr	23Cr
Depreciation & Amortization - CF	25Cr	26Cr	28Cr	31Cr	36Cr
Amortization of Goodwill and Intangible Assets - (CF)	83.12L	97.59L	1.32Cr	1.27Cr	2.13Cr
Depreciation & Amortization, Total	26Cr	27Cr	29Cr	33Cr	38Cr
Amortization of Deferred Charges, Total - (CF)	21.11L	22.99L	34.29L	40.18L	53.4L
(Gain) Loss From Sale Of Asset	35.72L	26.4L	9L	10.08L	70.76L
(Gain) Loss on Sale of Investments - (CF)	-1.34Cr	-2.34Cr	-2.07Cr	-2.38Cr	-2.07Cr
Asset Writedown & Restructuring Costs	9L	34T	-	-	-
(Income) Loss On Equity Investments - (CF)	-	-	-	51T	-
Stock-Based Compensation (CF)	69.88L	62.9L	1.42Cr	1.09Cr	-4L
Provision and Write-off of Bad Debts	-20.15L	13.06L	2L	-54T	39.06L
Other Operating Activities, Total	2.79Cr	4.06Cr	3.36Cr	5.52Cr	5.34Cr
Change In Accounts Receivable	-1.5Cr	-93.16L	-3.53Cr	-2.47Cr	6.28Cr
Change In Inventories	1.13Cr	-3.17Cr	-4.64Cr	-4.79Cr	5.63Cr
Change In Accounts Payable	1.35Cr	5.92Cr	-2.63Cr	4.58Cr	-97.41L
Change in Unearned Revenues	24Cr	17Cr	6.15Cr	6.19Cr	5.08Cr
Change in Other Net Operating Assets	-	-1.03Cr	-30T	-2L	-1.8Cr
Cash from Operations	68Cr	67Cr	38Cr	63Cr	80Cr
Capital Expenditure	-6.75Cr	-13Cr	-14Cr	-16Cr	-11Cr
Sale of Property, Plant, and Equipment	31.84L	-	2L	6L	26.93L
Cash Acquisitions	-55.29L	-1.13Cr	-42.02L	-74.96L	-25Cr
Divestitures	-2Cr	36.63L	-21.25L	-	80T
Investment in Marketable and Equity Securities, Total	-29Cr	-24Cr	20Cr	-55Cr	-41.34L
Other Investing Activities, Total	69.5L	-	-	60.62L	2Cr
Cash from Investing	-37Cr	-39Cr	5.36Cr	-71Cr	-34Cr
Long-Term Debt Issued, Total	-	-	-	-	16Cr
Total Debt Issued	-	-	-	-	16Cr
Long-Term Debt Repaid, Total	-17Cr	-18Cr	-23Cr	-23Cr	-27Cr
Total Debt Repaid	-17Cr	-18Cr	-23Cr	-23Cr	-27Cr
Issuance of Common Stock	-	1.83Cr	39.76L	51Cr	-
Repurchase of Common Stock	-	-	-	-	-
Common Dividends Paid	-11Cr	-8.12Cr	-20Cr	-8.7Cr	-11Cr
Common & Preferred Stock Dividends Paid	-11Cr	-8.12Cr	-20Cr	-8.7Cr	-11Cr
Other Financing Activities, Total	68.93L	-2.44Cr	-11.03L	-5.37Cr	50.59L
Cash from Financing	-27Cr	-27Cr	-43Cr	13Cr	-22Cr
Foreign Exchange Rate Adjustments	5L	2L	40.3L	1.21Cr	-5L
Net Change in Cash	3.87Cr	1.37Cr	68.36L	6.02Cr	23Cr
Supplemental Items
Cash Interest Paid	11.03L	17T	-	-	28.81L
Cash Income Tax Paid (Refund)	3.67Cr	4.59Cr	2.71Cr	2.82Cr	4.25Cr
Levered Free Cash Flow	56Cr	50Cr	20Cr	44Cr	106.66Cr
Unlevered Free Cash Flow	58Cr	52Cr	21Cr	45Cr	108.38Cr
Change In Net Working Capital	-25Cr	-21Cr	4.37Cr	-10Cr	-62Cr
Net Debt Issued / Repaid	-17Cr	-18Cr	-23Cr	-23Cr	-12Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	6.5	7.03	3.41	5.8	5.1
Return on Total Capital	19.94	22.44	11.25	15.82	12.46
Return On Equity %	157.33	103.33	47.47	44.37	27.91
Return on Common Equity	160.41	97.17	46.23	43.54	26.16
Margin Analysis
Gross Profit Margin %	46.57	46.82	43.89	45.55	46.26
SG&A Margin	32.9	32.12	35.18	32.47	33.04
EBITDA Margin %	20.12	20.01	14.79	18.01	17.51
EBITA Margin %	14.12	15.01	9.1	13.13	12.85
EBIT Margin %	13.57	14.46	8.29	12.54	12.02
Income From Continuing Operations Margin %	10.12	11.7	6.76	10.73	9.82
Net Income Margin %	10.04	10.86	6.3	10.05	8.88
Net Avail. For Common Margin %	10.04	10.86	6.3	10.05	8.88
Normalized Net Income Margin	7.35	7.39	4.05	7.06	6.44
Levered Free Cash Flow Margin	37.52	28.25	12	20.32	41.47
Unlevered Free Cash Flow Margin	38.59	29.1	12.94	21.05	42.13
Asset Turnover
Asset Turnover	0.77	0.78	0.66	0.74	0.68
Fixed Assets Turnover	1.85	2.3	1.99	2.36	2.68
Receivables Turnover (Average Receivables)	44.86	45.16	32.78	34.86	42.07
Inventory Turnover (Average Inventory)	7.44	8.3	5.75	5.61	6.3
Short Term Liquidity
Current Ratio	0.62	0.71	0.65	0.94	0.8
Quick Ratio	0.54	0.61	0.51	0.81	0.7
Operating Cash Flow to Current Liabilities	0.43	0.36	0.2	0.3	0.29
Days Sales Outstanding (Average Receivables)	8.16	8.08	11.13	10.47	8.7
Days Outstanding Inventory (Average Inventory)	49.19	43.97	63.44	65.1	58.06
Average Days Payable Outstanding	11.28	6.15	4.39	4.4	6.91
Cash Conversion Cycle (Average Days)	46.07	45.9	70.19	71.17	59.85
Long Term Solvency
Total Debt/Equity	366.5	196.34	258.73	67.5	74.91
Total Debt / Total Capital	78.56	66.25	72.12	40.3	42.83
LT Debt/Equity	261.49	134.18	184.4	47.2	50.29
Long-Term Debt / Total Capital	56.05	45.28	51.4	28.18	28.75
Total Liabilities / Total Assets	93.31	89.4	91.86	74.74	77.2
EBIT / Interest Expense	7.87	10.63	5.49	10.84	11.22
EBITDA / Interest Expense	17.78	21.9	17.37	24.05	24.91
(EBITDA - Capex) / Interest Expense	15.18	16.4	11.68	17.63	20.77
Total Debt / EBITDA	1.12	0.97	1.22	0.94	1.06
Net Debt / EBITDA	-0.62	-1.07	-0.9	-1.69	-1.6
Total Debt / (EBITDA - Capex)	1.31	1.3	1.82	1.29	1.28
Net Debt / (EBITDA - Capex)	-0.73	-1.43	-1.33	-2.31	-1.92
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	7.02	18.46	-8.16	31.16	19.91
Gross Profit, 1 Yr. Growth %	-1.17	19.11	-13.91	36.12	21.79
EBITDA, 1 Yr. Growth %	8.14	17.8	-32.12	59.63	16.57
EBITA, 1 Yr. Growth %	1.66	25.92	-44.32	89.1	17.35
EBIT, 1 Yr. Growth %	1.45	26.26	-47.36	98.17	14.97
Earnings From Cont. Operations, 1 Yr. Growth %	3.23	36.9	-46.95	108.21	9.71
Net Income, 1 Yr. Growth %	7.58	28.16	-46.71	109.15	5.94
Normalized Net Income, 1 Yr. Growth %	8.05	19.15	-49.61	128.36	9.48
Diluted EPS Before Extra, 1 Yr. Growth %	7.57	28.16	-46.79	82.26	5.32
Accounts Receivable, 1 Yr. Growth %	21.05	14.89	36.62	13.61	-13.13
Inventory, 1 Yr. Growth %	-22.27	41.63	38.49	24.92	-10.46
Net Property, Plant and Equip., 1 Yr. Growth %	-11.34	3.12	9.42	10.98	1.04
Total Assets, 1 Yr. Growth %	15.65	17.79	0.73	32.32	29.51
Tangible Book Value, 1 Yr. Growth %	-31.51	-78.36	234.42	-655.29	-111.78
Common Equity, 1 Yr. Growth %	197.59	82.69	-26.66	324.85	17.8
Cash From Operations, 1 Yr. Growth %	46.88	-1.56	-42.98	63.75	27.36
Capital Expenditures, 1 Yr. Growth %	-37.39	97.27	5.72	13.1	-28.29
Levered Free Cash Flow, 1 Yr. Growth %	-	-10.8	-61	122.12	144.64
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-10.68	-59.16	113.24	140.05
Dividend Per Share, 1 Yr. Growth %	-	-	-	24.65	12.51
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	12.59	4.3	9.75	25.41
Gross Profit, 2 Yr. CAGR %	-	8.49	1.26	8.25	28.75
EBITDA, 2 Yr. CAGR %	-	12.87	-10.58	4.13	36.42
EBITA, 2 Yr. CAGR %	-	13.14	-16.27	2.67	48.97
EBIT, 2 Yr. CAGR %	-	13.18	-18.47	2.21	50.94
Earnings From Cont. Operations, 2 Yr. CAGR %	-	18.88	-14.78	5.1	51.14
Net Income, 2 Yr. CAGR %	-	17.42	-17.35	5.58	48.85
Normalized Net Income, 2 Yr. CAGR %	-	13.46	-22.52	7.27	58.11
Diluted EPS Before Extra, 2 Yr. CAGR %	-	17.42	-17.42	-1.52	38.55
Accounts Receivable, 2 Yr. CAGR %	-	17.93	25.29	24.58	-0.66
Inventory, 2 Yr. CAGR %	-	4.93	40.06	31.53	5.76
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-4.38	6.23	10.2	5.89
Total Assets, 2 Yr. CAGR %	-	16.71	8.93	15.45	30.91
Tangible Book Value, 2 Yr. CAGR %	-	-61.5	-14.93	330.93	-19.11
Common Equity, 2 Yr. CAGR %	-	133.17	15.75	76.52	123.71
Cash From Operations, 2 Yr. CAGR %	-	20.25	-25.08	-3.37	44.41
Capital Expenditures, 2 Yr. CAGR %	-	11.13	44.42	9.35	-9.94
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-41.02	-6.91	133.11
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-39.61	-6.66	126.25
Dividend Per Share, 2 Yr. CAGR %	-	-	-	-	17.96
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	5.2	12.58	13.04
Gross Profit, 3 Yr. CAGR %	-	-	0.45	11.76	12.59
EBITDA, 3 Yr. CAGR %	-	-	-4.73	8.5	8.13
EBITA, 3 Yr. CAGR %	-	-	-10.68	9.9	7.35
EBIT, 3 Yr. CAGR %	-	-	-12.31	9.67	6.3
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-9.15	14.78	6.61
Net Income, 3 Yr. CAGR %	-	-	-9.76	12.62	5.7
Normalized Net Income, 3 Yr. CAGR %	-	-	-13.44	11.09	8
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-9.81	7.52	0.71
Accounts Receivable, 3 Yr. CAGR %	-	-	23.86	21.27	10.47
Inventory, 3 Yr. CAGR %	-	-	15.1	34.82	15.71
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	0.02	7.79	7.06
Total Assets, 3 Yr. CAGR %	-	-	11.12	16.23	19.96
Tangible Book Value, 3 Yr. CAGR %	-	-	-20.86	58.98	29.83
Common Equity, 3 Yr. CAGR %	-	-	58.57	78.55	54.26
Cash From Operations, 3 Yr. CAGR %	-	-	-6.23	-2.77	5.94
Capital Expenditures, 3 Yr. CAGR %	-	-	9.3	33.12	-5
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-8.22	28.47
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-8.02	27.88
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-	12.86
Gross Profit, 5 Yr. CAGR %	-	-	-	-	10.93
EBITDA, 5 Yr. CAGR %	-	-	-	-	10
EBITA, 5 Yr. CAGR %	-	-	-	-	9.63
EBIT, 5 Yr. CAGR %	-	-	-	-	9
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	11.36
Net Income, 5 Yr. CAGR %	-	-	-	-	10.24
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	10.15
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	7.09
Accounts Receivable, 5 Yr. CAGR %	-	-	-	-	13.4
Inventory, 5 Yr. CAGR %	-	-	-	-	11.27
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-	2.33
Total Assets, 5 Yr. CAGR %	-	-	-	-	18.65
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	-20.17
Common Equity, 5 Yr. CAGR %	-	-	-	-	81.97
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	11.45
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	1.15